Key Financial Data Of Reporting Company

Chordia Therapeutics,Inc - Filing #7315839

Concept As at
2024-05-31
2024-03-01 to
2024-05-31
2023-09-01 to
2024-05-31
As at
2023-08-31
2022-09-01 to
2023-08-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-1,175,664,000 JPY
225,761,000 JPY
Profit (loss)
-1,177,479,000 JPY
223,341,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
Share capital
90,000,000 JPY
90,000,000 JPY
Total number of issued shares
56,443,800 xbrli:shares
56,443,800 xbrli:shares
Net assets
3,323,402,000 JPY
4,500,881,000 JPY
Total assets
3,462,039,000 JPY
4,909,123,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-6.64
-20.86
3.96
Diluted earnings per share
Equity-to-asset ratio
0.952 xbrli:pure
0.912 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.